Back to Journals » Drug Design, Development and Therapy » Volume 12
Review
CTL019 (tisagenlecleucel): CAR-T therapy for relapsed and refractory B-cell acute lymphoblastic leukemia
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
39,495 | Dovepress* | 19,912+ | 2,551 | 22,463 | |
PubMed Central* | 19,583 | 3,047 | 22,630 | ||
Totals | 39,495 | 5,598 | 45,093 | ||
*Since 12 November 2018 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
11 | 1 | 0 | 0 | 1 | 9 |
View citations on PubMed Central and Google Scholar